NCT06714227Completed
Genetics of Prostate Cancer in Young Patients
Source: ClinicalTrials.gov · Last updated 3 Dec 2024
Brief summary (registry, in English)
The aim of the study is to identify genetic variants in genes responsible or potentially responsible for the etiology of prostate cancer in a population of patients with early onset of the malignancy.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 50 (actual)
- First submitted
- 28 Nov 2024
- Start date
- 25 Sept 2023
- Primary completion date
- 11 Jun 2024
- Lead sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Diseases
- Prostate cancer
- NCT number
- NCT06714227
What you commit to
- Study type: Observational
- Participants enrolled: 50
- From 25 Sept 2023 to the primary completion date, 11 Jun 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- None
Who the study is looking for
- Patients with histologic or cytologic diagnosis of prostate cancer
- Age ≥18 years and ≤55 years at first diagnosis of prostate carcinoma
- Availability of clinical and instrumental data related to prostate cancer
- Patients who knowingly express willingness to participate in the study after signing written informed consent
Age in the registry: 18 years to 55 years · Sex: Male · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| IRCCS Azienda Ospedaliero-Universitaria di Bologna Coordinator of this site? Confirm its status | Bologna | Italy | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.